GlassScriptPhysician profile
James Ryan Altman
NPI 1194928457
$9,797.64
in general payments reported to CMS, 2019-2025
28 companies · $1,438 in 2025
The $1,438 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,758 · 2020: $247 · 2021: $321 · 2022: $986 · 2023: $2,557 · 2024: $1,490 · 2025: $1,438.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,108 · Travel and Lodging: $378.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,107.76 |
| Travel and Lodging | $377.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,972.40 | 2021-2025 | Micra, Azure Xt Dr Mri Surescan, Omniasecure Mri Surescan |
| Abbott Laboratories | $1,513.47 | 2019-2024 | Jot Dx |
| Novartis Pharmaceuticals Corporation | $1,427.80 | 2019-2025 | |
| Shockwave Medical, INC | $663.19 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Amgen INC. | $573.82 | 2019-2025 | Repatha, Repatha |
| Pfizer INC. | $571.13 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $542.59 | 2019-2025 | Wainua |
| Boston Scientific Corporation | $538.27 | 2019-2025 | Watchman Access System, Bodyguardian |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $394.76 | 2019-2025 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $279.20 | 2020-2025 | Camzyos, Eliquis |
| Medtronic Vascular, INC. | $234.50 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $131.36 | 2022-2024 | Xarelto |
| Edwards Lifesciences Corporation | $102.90 | 2019 | |
| Merck Sharp & Dohme LLC | $100.83 | 2022-2023 | Verquvo |
| Boehringer Ingelheim Pharmaceuticals, INC. | $98.04 | 2022-2025 | Jardiance |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alnylam Pharmaceuticals INC. | $86.83 | 2023-2025 | Onpattro |
| Atricure, INC. | $81.78 | 2025 | Epi-Sense Guided Coagulation System With Visitrax |
| Novo Nordisk INC | $77.11 | 2025 | Wegovy |
| Kiniksa Pharmaceuticals International, Plc | $74.02 | 2024 | Arcalyst |
| Kiniksa Pharmaceuticals, LTD. | $56.94 | 2022-2023 | Arcalyst |
| Scpharmaceuticals INC. | $49.94 | 2023-2024 | |
| Esperion Therapeutics, INC. | $48.78 | 2023-2024 | Nexletol |
| Actelion Pharmaceuticals US, INC. | $45.61 | 2024-2025 | Uptravi, Opsynvi, Opsumit |
| Lundbeck LLC | $30.84 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $30.24 | 2024-2025 | |
| Impulse Dynamics (USA) INC. | $26.79 | 2023 | Optimizer |
| Corcept Therapeutics | $22.56 | 2025 | Korlym |
| Philips North America LLC | $21.94 | 2025 | Event |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Altman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.